-
Alvogen unit appeals court loss in bid to market Xifaxan generic
21 Apr 2025 19:51 GMT
-
Govt Bans 35 Combination Drugs, See Full List
16 Apr 2025 17:57 GMT
… provisions of the New Drugs and Clinical Trials (NDCT) Rules, 2019. … , CDSCO (FDC Division), from FDA Bhawan, New Delhi.
“It … may lead to adverse drug reactions, drug interactions, and other health … IP 75m S ru
24.
Rifaximin BP 200mg & Metronidazole …
-
Keeping Watch on the Inflation Reduction Act: Medicare Poses Part D Formulary Access Challenges
16 Apr 2025 07:21 GMT
… Medicare include antidepressants, antipsychotics, anticonvulsants; immunosuppressants for treatment … Food and Drug Administration (FDA) orange book … , osimertinibmesylate, palbociclib, pomalidomide, rifaximin, riociguat, rivaroxaban, ruxolitinibphosphate, …
-
Statin-Antibiotic Combo Fails in Decompensated Cirrhosis
07 Apr 2025 11:41 GMT
Adding combination treatment with simvastatin and rifaximin to … Pose told Medscape Medical News. “Rifaximin targets bacterial translocation … .”
“Randomized clinical trials showed that not … lowering serum cholesterol, statins have pleiotropic effects …
-
Dementia Associated With Alzheimer’S Disease Clinical Trials And Studies 2025: EMA, PDMA, FDA Approvals, Mechanism Of Action, ROA, NDA, IND, And Companies
27 Mar 2025 01:06 GMT
… U.S. Food and Drug Administration (FDA) has closed the … ., Eisai Inc., Shanghai Hengrui Pharmaceutical Co., Ltd and others.
Promising … Fumarate, DMB-I (Dimebon), Rifaximin SSD 40 mg IR tablet … drug is in Phase III stage of its clinical trial for the treatment …
-
Bausch: Potential Breakthrough in Depression Treatment to Unlock $3B Opportunity?
21 Mar 2025 09:57 GMT
… pharmaceutical companies have introduced several blockbuster medications … Treatment-Resistant Depression: A Profound Unmet Medical) Need
Despite their widespread use, antidepressant medications … and Drug Administration (FDA) approved … medications such as Xifaxan …
-
‘No beneficial effects’ from simvastatin plus rifaximin for decompensated cirrhosis
18 Mar 2025 11:59 GMT
… 27441.
To determine whether treatment with simvastatin plus rifaximin (Xifaxan, Bausch Health), along … , parallel-group, placebo-controlled trial of 237 adult patients (mean … rifaximin per day (n = 117) or identical-appearing placebo of both medications …
-
CMS doubles down on Medicare drug price negotiations
17 Mar 2025 13:46 GMT
… , Calquence, Austedo, Breo Ellipta, Tradjenta, Xifaxan, Vraylar, Janumet, and Otezla to … negotiations aimed at reducing drug costs for Medicare beneficiaries.
On March 14 … about 14% of Medicare Part D's prescription drug costs, according …
-
FDA Approved Drug Products Approval List January 2025
11 Mar 2025 11:43 GMT
Approval Date Drug Name Submission Active Ingredients Company … ;2025 RIFAXIMINANDA #218862 ORIG-1 RIFAXIMIN AMNEAL EU LTD Tentative Approval … #761036 SUPPL-51 DARATUMUMAB JANSSEN BIOTECH Approval 01/24…
-
Health Care Week in Review: HHS Releases Notice of Benefit and Payment Parameters for 2026 and CMS Identifies Drugs for Second Round of Medicare Price Negotiations
21 Jan 2025 03:58 GMT
… available for specific medical treatments and technologies through … For all three drugs, FDA issued an approval despite … its confirmatory trial delayed. OIG recommended FDA define … XIFAXAN
VRAYLAR
JANUMET; JANUMET XR
Otezla
On January 15, 2025, the Drug …
About
© 1995-2025